Changes in Gut Microbiome Associated With Co-Occurring Symptoms Development During Chemo-Radiation for Rectal Cancer: A Proof of Concept Study

Abstract

Purpose:

To examine a) whether there are significant differences in the severity of symptoms of fatigue, sleep disturbance, or depression between patients with rectal cancer who develop co-occurring symptoms and those with no symptoms before and at the end of chemotherapy and radiation therapy (CRT); b) differences in gut microbial diversity between those with co-occurring symptoms and those with no symptoms; and c) whether before-treatment diversity measurements and taxa abundances can predict co-occurrence of symptoms.

Methods:

Stool samples and symptom ratings were collected from 31 patients with rectal cancer prior to and at the end of (24–28 treatments) CRT. Descriptive statistics were computed and the Mann-Whitney U test was performed for symptoms. Gut microbiome data were analyzed using R’s vegan package software.

Results:

Participants with co-occurring symptoms reported greater severity of fatigue at the end of CRT than those with no symptoms. Bacteroides and Blautia2 abundances differed between participants with co-occurring symptoms and those with no symptoms. Our random forest classification (unsupervised learning algorithm) predicted participants who developed co-occurring symptoms with 74% accuracy, using specific phylum, family, and genera abundances as predictors.

Conclusion:

Our preliminary results point to an association between the gut microbiota and co-occurring symptoms in rectal cancer patients and serves as a first step in potential identification of a microbiota-based classifier.

Keywords

gut microbiome rectal cancer co-occurrence of symptoms chemotherapy and radiation therapy

Get full access to this article

View all access options for this article.

References

Agasi-Idenburg

S. C.

Thong

M. S.

Punt

C. J.

Stuiver

M. M.

Aaronson

N. K.

(2017). Comparison of symptom clusters associated with fatigue in older and younger survivors of colorectal cancer. Supportive Care in Cancer, 25(2), 625–632. https://doi.org/10.1007/s00520-016-3451-4

Bagby

R. M.

Ryder

A. G.

Schuller

D. R.

Marshall

M. B.

(2004). The Hamilton depression rating scale: Has the gold standard become a lead weight? American Journal of Psychiatry, 161(12), 2163–2177. https://doi.org/10.1176/appi.ajp.161.12.2163

Bajic

J. E.

Johnston

I. N.

Howarth

G. S.

Hutchinson

M. R.

(2018). From the bottom-up: Chemotherapy and gut-brain axis dysregulation. Frontiers in Behavioral Neuroscience, 12, 104. https://doi.org/10.3389/fnbeh.2018.00104

Baxter

N. T.

Zackular

J. P.

Chen

G. Y.

Schloss

P. D.

(2014). Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome, 2, 20. https://doi.org/10.1186/2049-2618-2-20

Berger

A. M.

Mooney

Alvarez-Perez

Breitbart

W. S.

Carpenter

K. M.

Cella

Cleeland

Dotan

Eisenberger

M. A.

Escalante

C. P.

Jacobsen

P. B.

Jankowski

LeBlanc

Ligibel

J. A.

Loggers

E. T.

Mandrell

Murphy

B. A.

Palesh

Pirl

W. F.

… Smith

(2015). Cancer-related fatigue, version 2.2015. Journal of the National Comprehensive Cancer Network, 13(8), 1012–1039. https://doi.org/10.6004/jnccn.2015.0122

Brunet

Burke

Grocott

M. P.

West

M. A.

Jack

(2017). The effects of exercise on pain, fatigue, insomnia, and health perceptions in patients with operable advanced stage rectal cancer prior to surgery: A pilot trial. BMC Cancer, 17(1), 153. https://doi.org/10.1186/s12885-017-3130-y

Buysse

D. J.

Moul

D. E.

Germain

Stover

Dodds

N. E.

Johnston

K. L.

Shablesky-Cade

M. A.

Pilkonis

P. A.

(2010). Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep, 33(6), 781–792.

Callahan

B. J.

McMurdie

P. J.

Rosen

M. J.

Han

A. W.

Johnson

A. J.

Holmes

S. P.

(2016). DADA2: High-resolution sample inference from Illumina amplicon data. Nature Methods, 13(7), 581–583. https://doi.org/10.1038/nmeth.3869

Cella

Eton

D. T.

Lai

J. S.

Peterman

A. H.

Merkel

D. E.

(2002). Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales. Journal of Pain and Symptom Management, 24(6), 547–561.

10.

Chen

Jiang

Zhong

Guo

Zhang

(2018). Chemoprevention of colorectal cancer by black raspberry anthocyanins involved the modulation of gut microbiota and SFRP2 demethylation. Carcinogenesis, 39(3), 471–481. https://doi.org/10.1093/carcin/bgy009

11.

Chen

X. H.

Wang

Chu

A. N.

Gong

Y. H.

Yuan

(2019). Mucosa-associated microbiota in gastric cancer tissues compared with non-cancer tissues. Frontiers in Microbiology, 10, 1261. https://doi.org/10.3389/fmicb.2019.01261

12.

Chiang

S. H.

K. Y.

Wang

S. Y.

Lin

C. C.

(2018). Change in symptom clusters in head and neck cancer patients undergoing postoperative radiotherapy: A longitudinal study. European Journal of Oncology Nursing, 35, 62–66. https://doi.org/10.1016/j.ejon.2018.01.014

13.

Chongpison

Hornbrook

M. C.

Harris

R. B.

Herrinton

L. J.

Gerald

J. K.

Grant

Bulkley

J. E.

Wendel

C. S.

Krouse

R. S.

(2016). Self-reported depression and perceived financial burden among long-term rectal cancer survivors. Psychooncology, 25(11), 1350–1356. https://doi.org/10.1002/pon.3957

14.

Faith

D. P.

(1992). Conservation evaluation and phylogenetic diversity. Biological Conservation, 61(1), 1–10. https://doi.org/10.1016/0006-3207(92)91201-3

15.

Flynn

K. J.

Ruffin

M. T.

Turgeon

D. K.

Schloss

P. D.

(2018). Spatial variation of the native colon microbiota in healthy adults. Cancer Prevention Research (Philadelphia, PA), 11(7), 393–402. https://doi.org/10.1158/1940-6207.capr-17-0370

16.

Forbes

J. D.

Van Domselaar

Bernstein

C. N.

(2016). Microbiome survey of the inflamed and noninflamed gut at different compartments within the gastrointestinal tract of inflammatory bowel disease patients. Inflammatory Bowel Diseases, 22(4), 817–825. https://doi.org/10.1097/mib.0000000000000684

17.

Furukawa

T. A.

Akechi

Azuma

Okuyama

Higuchi

(2007). Evidence-based guidelines for interpretation of the Hamilton rating scale for depression. Journal of Clinical Psychopharmacology, 27(5), 531–534. https://doi.org/10.1097/JCP.0b013e31814f30b1

18.

Gonzalez-Mercado

V. J.

Perez-Santiago

Lyon

Dilan-Pantojas

Henderson

McMillan

Groer

Kane

Marrero

Pedro

Saligan

L. N.

(2020). The role of gut microbiome perturbation in fatigue induced by repeated stress from chemoradiotherapy: A proof of concept study. Advances in Medicine, 2020, https://doi.org/10.1155/2020/6375876

19.

González-Mercado

V. J.

Sakar

Penedo

F. J.

Pérez-Santiago

Mcmillan

Marrero

S. J

Marrero-Falcón

M. A.

Munro

C. L.

(2019). Gut microbiota perturbation is associated with acute sleep disturbance among rectal cancer patients. Journal of Sleep Research, 2019(00), e12915. https://doi.org/10.1111/jsr.12915

20.

Gosselin

T. K.

Beck

Abbott

D. H.

Grambow

S. C.

Provenzale

Berry

Kahn

K. L.

Malin

J. L.

(2016). The symptom experience in rectal cancer survivors. Journal of Pain and Symptom Management, 52(5), 709–718. https://doi.org/10.1016/j.jpainsymman.2016.05.027

21.

Gwede

C. K.

Small

B. J.

Munster

P. N.

Andrykowski

M. A.

Jacobsen

P. B.

(2008). Exploring the differential experience of breast cancer treatment-related symptoms: A cluster analytic approach. Supportive Care in Cancer, 16(8), 925–933. https://doi.org/10.1007/s00520-007

22.

Hamilton

(1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62. https://doi.org/10.1136/jnnp.23.1.56

23.

Hoehn

R. S.

Seitz

A. P.

Jernigan

P. L.

Gulbins

Edwards

M. J.

(2016). Ischemia/reperfusion injury alters sphingolipid metabolism in the gut. Cellular Physiology and Biochemistry, 39(4), 1262–1270. https://doi.org/10.1159/000447831

24.

Jakobsson

Ahlberg

Taft

Ekman

(2010). Exploring a link between fatigue and intestinal injury during pelvic radiotherapy. The Oncologist, 15(9), 1009–1015. https://doi.org/10.1634/theoncologist.2010-0097

25.

Jenq

R. R.

Taur

Devlin

S. M.

Ponce

D. M.

Goldberg

J. D.

Ahr

K. F.

Littmann

E. R.

Ling

Gobourne

A. C.

Miller

L. C.

Docampo

M. D.

Peled

J. U.

Arpaia

Cross

J. R.

Peets

T. K.

Lumish

M. A.

Shono

Dudakov

J. A.

Poeck

… van den Brink

M. R.

(2015). Intestinal blautia is associated with reduced death from graft-versus-host disease. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 21(8), 1373–1383. https://doi.org/10.1016/j.bbmt.2015.04.016

26.

Johnston

B. C.

Patrick

D. L.

Thorlund

Busse

J. W.

da Costa

B. R.

Schunemann

H. J.

Guyatt

G. H.

(2013). Patient-reported outcomes in meta-analyses-part 2: Methods for improving interpretability for decision-makers. Health and Quality of Life Outcomes, 11, 211. https://doi.org/10.1186/1477-7525-11-211

27.

Jordan

K. R.

Loman

B. R.

Bailey

M. T.

Pyter

L. M.

(2018). Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities. Cancer, 124(20), 3990–3999. https://doi.org/10.1002/cncr.31584

28.

Kappelman

M. D.

Long

M. D.

Martin

DeWalt

D. A.

Kinneer

P. M.

Chen

Lewis

J. D.

Sandler

R. S.

(2014). Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology, 12(8), 1315–1323 e1312. https://doi.org/10.1016/j.cgh.2013.10.019

29.

Larasati

R. A.

Harbuwono

D. S.

Rahajeng

Pradipta

Nuraeni

H. S.

Susilowati

Wibowo

(2019). The role of butyrate on monocyte migration and inflammation response in patient with type 2 diabetes mellitus. Biomedicines, 7(4). https://doi.org/10.3390/biomedicines7040074

30.

Hao

Fan

Zhang

(2018). The role of microbiome in insomnia, circadian disturbance and depression. Frontiers in Psychiatry, 9, 669. https://doi.org/10.3389/fpsyt.2018.00

31.

Liaw

Wiener

(2002). Classification and regression by randomForest. R News, 2(3), 18–22.

32.

Luu

T. H.

Michel

Bard

J. M.

Dravet

Nazih

Bobin-Dubigeon

(2017). Intestinal proportion of Blautia sp. is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer. Nutrition and Cancer, 69(2), 267–275. https://doi.org/10.1080/01635581.2017.1263750

33.

Lynch

K. D.

Dickinson

Hsiao

C. P.

Lukkahatai

Gonzalez-Marrero

McCabe

Saligan

L. N.

(2016). Biological basis for the clustering of symptoms. Seminars in Oncology Nursing, 32(4), 351–360. https://doi.org/10.1016/j.soncn.2016.08.002

34.

National Comprehensive Cancer Network. (2016). Clinical practice guidelines in oncology; Rectal Cancer. https://www.nccn.org/Store/Login/Register.aspx?returnurl=https%3a%2f%2fwww.nccn.org%2fprofessionals%2fphysician_gls%2fpdf%2frectal.pdf

35.

Nho

J. H.

Reul Kim

Nam

J. H.

(2017). Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy. European Journal of Oncology Nursing, 30, 8–14. https://doi.org/10.1016/j.ejon.2017.07.007

36.

Park

J. S.

Lee

E. J.

Lee

J. C.

Kim

W. K.

Kim

H. S.

(2007). Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: Involvement of NF-kappaB and ERK signaling pathways. International Immunopharmacology, 7(1), 70–77. https://doi.org/10.1016/j.intimp.2006.08.015

37.

Perez

N. B.

Dorsen

Squires

(2020). Dysbiosis of the gut microbiome: A concept analysis. Journal of Holistic Nursing, 38(2), 223–232. https://doi.org/10.1177/0898010119879527

38.

Price

M. N.

Dehal

P. S.

Arkin

A. P.

(2009). FastTree: Computing large minimum evolution trees with profiles instead of a distance matrix. Molecular Biology and Evolution, 26(7), 1641–1650. https://doi.org/10.1093/molbev/msp077

39.

Rea

Dinan

T. G.

Cryan

J. F.

(2020). Gut microbiota: A perspective for psychiatrists. Neuropsychobiology, 79(1), 50–62. https://doi.org/10.1159/000504495

40.

Schalet

B. D.

Pilkonis

P. A.

Dodds

Johnston

K. L.

Yount

Riley

Cella

(2016). Clinical validity of PROMIS depression, anxiety, and anger across diverse clinical samples. Journal of Clinical Epidemiology, 73, 119–127. https://doi.org/10.1016/j.jclinepi.2015.08.036

41.

Schoepfer

A. M.

Vavricka

Zahnd-Straumann

Straumann

Beglinger

(2012). Monitoring inflammatory bowel disease activity: Clinical activity is judged to be more relevant than endoscopic severity or biomarkers. Journal of Crohn’s & Colitis, 6(4), 412–418. https://doi.org/10.1016/j.crohns.2011.09.008

42.

Schwab

Berry

Rauch

Rennisch

Ramesmayer

Hainzl

Heider

Decker

Kenner

Müller

Strobl

Wagner

Schleper

Loy

Urich

(2014). Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. The ISME Journal, 8(5), 1101–1114. https://doi.org/10.1038/ismej.2013.223

43.

Shaw

K. A.

Bertha

Hofmekler

Chopra

Vatanen

Srivatsa

Prince

Kumar

Sauer

Zwick

M. E.

Satten

G. A.

Kostic

A. D.

Mulle

J. G.

Xavier

R. J.

Kugathasan

(2016). Dysbiosis, inflammation, and response to treatment: A longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Medicine, 8(1), 75. https://doi.org/10.1186/s13073-016-0331-y

44.

Siegel

R. L.

Miller

K. D.

Jemal

(2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7–30. https://doi.org/10.3322/caac.21590

45.

Sullivan

C. W.

Leutwyler

Dunn

L. B.

Cooper

B. A.

Paul

S. M.

Levine

J. D.

Hammer

Conley

Y. P.

Miaskowski

C. A.

(2018). Stability of symptom clusters in patients with breast cancer receiving chemotherapy. Journal of Pain and Symptom Management, 55(1), 39–55. https://doi.org/10.1016/j.jpainsymman.2017.08.008

46.

Sze

M. A.

Schloss

P. D.

(2018). Leveraging existing 16 S rRNA gene surveys to identify reproducible biomarkers in individuals with colorectal tumors. MBio, 9(3). https://doi.org/10.1128/mBio.00630-18

47.

Tantoy

I. Y.

Cataldo

J. K.

Aouizerat

B. E.

Dhruva

Miaskowski

(2016). A review of the literature on multiple co-occurring symptoms in patients with colorectal cancer who received chemotherapy alone or chemotherapy with targeted therapies. Cancer Nursing, 39(6), 437–445. https://doi.org/10.1097/ncc.0000000000000343

48.

Tantoy

I. Y.

Cooper

B. A.

Dhruva

Cataldo

Paul

S. M.

Conley

Y. P.

Hammer

Wright

Dunn

L. B.

Levine

J. D.

Miaskowski

(2018). Changes in the occurrence, severity, and distress of symptoms in patients with gastrointestinal cancers receiving chemotherapy. Journal of Pain Symptom Management, 55(3), 808–834. https://doi.org/10.1016/j.jpainsymman.2017.10.004

49.

Thomas

A. M.

Jesus

E. C.

Lopes

Aguiar

Jr Begnami

M. D.

Rocha

R. M.

Carpinetti

P. A.

Camargo

A. A.

Hoffmann

Freitas

H. C.

Silva

I. T.

Nunes

D. N.

Setubal

J. C.

Dias-Neto

(2016). Tissue-associated bacterial alterations in rectal carcinoma patients revealed by 16 S rRNA community profiling. Frontiers in Cellular and Infection Microbiology, 6, 179. https://doi.org/10.3389/fcimb.2016.00179

50.

Touchefeu

Montassier

Nieman

Gastinne

Potel

Bruley des Varannes

Le Vacon

de La Cochetiere

M. F.

(2014). Systematic review: The role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis—Current evidence and potential clinical applications. Alimentary Pharmacology & Therapeutics, 40(5), 409–421. https://doi.org/10.1111/apt.12878

51.

Wong

J. M.

de Souza

Kendall

C. W.

Emam

Jenkins

D. J.

(2006). Colonic health: Fermentation and short chain fatty acids. Journal of Clinical Gastroenterology, 40(3), 235–243. https://doi.org/10.1097/00004836-200603000-00015

52.

Yost

K. J.

Eton

D. T.

Garcia

S. F.

Cella

(2011). Minimally important differences were estimated for six patient-reported outcomes measurement information system-cancer scales in advanced-stage cancer patients. Journal of Clinical Epidemiology, 64(5), 507–516. https://doi.org/10.1016/j.jclinepi.2010.11.018

53.

Yuan

Zhang

Yang

Mushtaq

Ullah

Shi

(2018). The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer. Biomedicine & Pharmacotherapy, 108, 184–193. https://doi.org/10.1016/j.biopha.2018.08.165

54.

Zhao

Lukiw

W. J.

(2018). Bacteroidetes neurotoxins and inflammatory neurodegeneration. Molecular Neurobiology, 55(12), 9100–9107. https://doi.org/10.1007/s12035-018-1015-y

55.

Zhong

Nyman

Fak

(2015). Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. Molecular Nutrition & Food Research, 59(10), 2066–2076. https://doi.org/10.1002/mnfr.201500187